Preventive Vaccines Market

Market Growth of Global Preventive vaccine to Remain Sluggish through 2020 - 2030

More than 200 preventive vaccines, developed by both industry and non-industry players, are being evaluated in clinical stages of development, claims Roots Analysis

Technical advances, especially in the field of biotechnology, have led to the development of several next generation preventive vaccines, including recombinant vaccines, viral vector based vaccines and DNA vaccines, which have been demonstrated to elicit powerful immune responses, resulting in the development of immunological memory.

The USD 94 billion (by 2030) financial opportunity within the global preventive vaccine market has been analyzed across the following segments:

Route of Administration

  • Intramuscular
  • Subcutaneous
  • Oral
  • Intravenous
  • Others

Type of Vaccine

  • Pneumococcal Conjugate Vaccine
  • Human Papilloma Virus Vaccine
  • Rotavirus Vaccine
  • Influenza Vaccine
  • MMR Vaccine
  • Tetanus and Diphtheria Booster Vaccine
  • Varicella Vaccine
  • DTaP-Hib-IPV Vaccine
  • DTaP-HepB-Hib-IPV Vaccine
  • Others

Type of Vaccine API

  • Live, Attenuated Vaccine
  • Inactivated Vaccine
  • Conjugate Vaccine
  • Subunit Vaccine
  • Toxoid Vaccine
  • Others

Target Patient Population

  • Pediatric Patients
  • Adult

Key Players

  • GlaxoSmithKline
  • Merck
  • Sanofi Pasteur
  • Pfizer
  • Emergent BioSolutions
  • CSL
  • Others

Key Geographical Regions

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

The Global Preventive Vaccines Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • Bio Farma
  • Emergent BioSolutions
  • GC Pharma
  • GlaxoSmithKline
  • Janssen
  • Merck
  • Novavax
  • Pfizer
  • Sanofi Pasteur
  • Valneva

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4.  Market Landscape

5. Company Competitiveness Analysis

6. Company Profiles

7. Clinical Trial Analysis

8. Ongoing Vaccine Development Initiatives for Complex Conditions

9. Funding and Investment Analysis

10. Market Sizing and Opportunity Analysis

11. Case-in-Point: Contract Manufacturing of Vaccines

12. Concluding Remarks

13. Executive Insights

14. Appendix 1: Tabulated Data

15. Appendix 2: List of Companies and Organizations

For more information, please click on the following link:    

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Write a Comment